Αρχική World News News digest – sponge on a string, junk food watershed, prostate cancer...

News digest – sponge on a string, junk food watershed, prostate cancer AI and mobile phones?

With news about the coronavirus pandemic developing daily, we’re pulling together the latest government and NHS health updates from across the UK in a separate blog post, which we’re updating regularly.

Sponge on a string could transform oesophageal cancer diagnosis

A new ‘sponge on a string’ test could identify 10 times more people with Barrett’s oesophagus – a precursor to oesophageal cancer – than current testing methods, according to our scientists. Find out more in our blog post and the Express & Star.

New obesity strategy launched in ‘landmark day for nation’s health’

The UK Government has launched a new strategy to tackle obesity in the UK. New measures include restrictions on junk food marketing on TV and online, along with bans on multi-buy offers and certain instore promotions on high fat food products. There are also new rules for displaying calories on restaurant menus. The new strategy arrives amid growing evidence of a link between obesity and an increased risk from COVID-19. Head over to our blog or BBC News for the story.

AI could help detect prostate cancer

Using artificial intelligence (AI) software to scan biopsy samples could help flag prostate cancers that may otherwise have gone undetected. Medical experts have said that while the algorithm could be useful in overcoming pathologists’ own biases, the findings don’t necessarily prove that the AI’s diagnosis can be considered superior to humans, and that more research with larger samples sizes is needed. More on this at iNews.

Scientists identify new drug target for aggressive breast cancer

iNews reports scientists have uncovered a way to slow breast cancer stem cell growth in the lab. The team were particularly interested in stem cells that are resistant to hormone therapy, which can often be present when breast cancers come back after treatment, and believe the target they’ve identified could open the door to new treatments. Dr Bruno Simões from the University of Manchester said: “There’s a very long way to go before we can say if this approach will help these women, but we are excited by our findings.”

‘Higher end of normal’ blood platelet count could indicate cancer

Blood platelet counts at the high end of normal could be linked to an increased risk of cancer in men aged 60 or over, according to new research by the University of Exeter. High platelet count (otherwise known as thrombocytosis) has previously been linked to cancer, but this study looked at the records of 300,000 patients with platelet counts that were at the high end of the normal range. But despite the size of the study, more research is needed to confirm the link and talk of a diagnostic tool may be premature. Read more at MedicalXpress.

Scientists develop new method to selectively kill off cancer cells

New Atlas reports on a new development where scientist use “synthetic lethality” – when a build-up of DNA errors that normally wouldn’t harm a cell suddenly become deadly – to selectively kill off cancer without harming healthy cells in the lab. It’s still early days, but researchers hope the study could open the door to new drug targets.

And finally…

Mobile phones and cancer have hit the headlines again, as new research claims to have found a link between levels of blue light – used in billboard ads as well as many tablet and mobile devices – and an increased risk of bowel cancer.

But despite some bold headlines, the study only compared levels of blue light in different neighbourhoods using satellite images, rather than looking at individual people’s exposure. The study found that residents in areas with the highest exposure to outdoor blue light – the same light used in many tablet and mobile devices – had a higher risk compared to those with the lowest exposure.

Experts have said that while the findings are ‘interesting’, the research wasn’t able to take in consideration several factors linked to bowel cancer, and it’s impossible to tell from this study whether artificial light causes the disease. More on this at Daily Mail and Sky News.

Scarlett Sangster is a writer for PA Media Group

More on this topic

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

ACHIEVE-2 Results of Oxaliplatin-Based Adjuvant Chemotherapy in Asian Patients with High-Risk Stage II Colon Cancer

The Asian researchers reported on 25 October 2020 in the Annals of Oncology that 3-month of combination therapy for adjuvant treatment of high-risk stage...

GreaterGood’s Mask Donations Are Helping LA Family Housing Keep Homeless People Safe

Due to the COVID-19 pandemic, people everywhere are uncertain about the future of their health, safety, and economic security. Homeless people and those who...

How I Found a Meaningful Career After Cancer

Jacky Costello is the founder and owner of a house cleaning company serving the greater Tampa Bay area in Florida. Through her company's partnership with...

Radiopharmaceuticals: Radiation Therapy Enters the Molecular Age

October 26, 2020, by NCI Staff Radiopharmaceuticals consist of a radioactive molecule, a targeting molecule, and a linker that joins the two. Credit: National Cancer Institute The...

FDA Grants Regular Approval to Venetoclax in Combination for Untreated Acute Myeloid Leukaemia

On 16 October 2020, the US Food and Drug Administration (FDA) granted regular approval to venetoclax (VENCLEXTA ®, AbbVie Inc. and Genentech Inc.) in...

EMA Recommends Granting a Marketing Authorisation for Lenalidomide Mylan

On 15 October 2020, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...